Maven Bio

Maven Bio is an AI research and intelligence platform for the life sciences industry. It answers questions about clinical trials, drug assets and therapeutic markets with cited responses grounded in primary sources, so an analyst can screen assets, size a market or track a competitor's pipeline without assembling the evidence by hand. The platform is built around the idea that every figure should trace back to the document it came from. It serves three buyer groups: pharma and biotech companies making strategic and competitive decisions, consultants delivering client work that needs primary source depth, and investment firms building theses backed by evidence. Capabilities that matter include Smart Tables, which compare hundreds of assets or trials from a single query; Report Builder, which synthesizes reports from primary sources with citations; and Research Agent, which takes a delegated research task and returns a finished analysis with structured data. Custom templates, structured alerts for market monitoring, integration with an internal knowledge base, and auditable accuracy through source citations round out the offering. Pricing is not published. Maven Bio sells through demos, and cost is quote based according to the organization and use case. Buyers should note that the platform is specialized for clinical and therapeutic market research; it is not a general purpose scientific literature assistant, and its value depends on the depth of its clinical trial and asset coverage for the therapeutic areas that matter to the buyer.